BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 36263632)

  • 1. PPP1R14D promotes the proliferation, migration and invasion of lung adenocarcinoma via the PKCα/BRAF/MEK/ERK signaling pathway.
    Cao H; Wang Z; Wang Y; Ye L; Li R; Xue Y; Li K; Di T; Li T; Fan Z; Liu Y; Guo J; Yao H; Ge C
    Int J Oncol; 2022 Dec; 61(6):. PubMed ID: 36263632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleophosmin promotes lung adenocarcinoma cell proliferation, migration and invasion by activating the EGFR/MAPK signaling pathway.
    Li M; Wu R; Zhu D; Wang L; Liu S; Wang R; Deng C; Zhang S; Chen M; Lu R; Zhu H; Mo M; Luo Z
    Oncol Rep; 2023 Jun; 49(6):. PubMed ID: 37165929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of PPP1R14D gene high expression in lung adenocarcinoma knocked out on proliferation and apoptosis of DMS53 cell.
    Tian Y; Guan L; Qian Y; Wu Y; Gu Z
    Clin Transl Oncol; 2022 Oct; 24(10):1914-1923. PubMed ID: 35579727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-6742-5p regulates the invasion and migration of lung adenocarcinoma cells via mediating FGF8/ERK12/MMP9/MMP2 signaling pathway.
    Song M; Xing X
    Aging (Albany NY); 2023 Jan; 15(1):53-69. PubMed ID: 36629518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TMEM9 promotes lung adenocarcinoma progression via activating the MEK/ERK/STAT3 pathway to induce VEGF expression.
    Wang Z; Zhao P; Tian K; Qiao Z; Dong H; Li J; Guan Z; Su H; Song Y; Ma X
    Cell Death Dis; 2024 Apr; 15(4):295. PubMed ID: 38664392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Junctional adhesion molecule-like protein promotes tumor progression via the Wnt/β-catenin signaling pathway in lung adenocarcinoma.
    Wu Q; Li R; Wang QX; Zhang MY; Liu TT; Qu YQ
    J Transl Med; 2022 Jun; 20(1):260. PubMed ID: 35672776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The novel circular RNA circ-CAMK2A enhances lung adenocarcinoma metastasis by regulating the miR-615-5p/fibronectin 1 pathway.
    Du J; Zhang G; Qiu H; Yu H; Yuan W
    Cell Mol Biol Lett; 2019; 24():72. PubMed ID: 31889960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDK10 suppresses metastasis of lung adenocarcinoma through inhibition of the ETS2/c-Raf/p-MEK/p-ERK signaling loop.
    Zhang X; Zhao Y; Yiminniyaze R; Zhu N; Zhang Y; Wumaier G; Xia J; Dong L; Zhou D; Wang J; Li C; Zhang Y; Li S
    Mol Carcinog; 2024 Jan; 63(1):61-74. PubMed ID: 37737453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EphA10 drives tumor progression and immune evasion by regulating the MAPK/ERK cascade in lung adenocarcinoma.
    Zhao W; Liu L; Li X; Xu S
    Int Immunopharmacol; 2022 Sep; 110():109031. PubMed ID: 35839564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STRIP2, a member of the striatin-interacting phosphatase and kinase complex, is implicated in lung adenocarcinoma cell growth and migration.
    Qiu LM; Sun YH; Chen TT; Chen JJ; Ma HT
    FEBS Open Bio; 2020 Mar; 10(3):351-361. PubMed ID: 31901223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mex3a interacts with LAMA2 to promote lung adenocarcinoma metastasis via PI3K/AKT pathway.
    Liang J; Li H; Han J; Jiang J; Wang J; Li Y; Feng Z; Zhao R; Sun Z; Lv B; Tian H
    Cell Death Dis; 2020 Aug; 11(8):614. PubMed ID: 32792503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SLC39A5 promotes lung adenocarcinoma cell proliferation by activating PI3K/AKT signaling.
    Liu Z; Hu Z; Cai X; Liu S
    Pathol Res Pract; 2021 Aug; 224():153541. PubMed ID: 34252710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RHOV promotes lung adenocarcinoma cell growth and metastasis through JNK/c-Jun pathway.
    Zhang D; Jiang Q; Ge X; Shi Y; Ye T; Mi Y; Xie T; Li Q; Ye Q
    Int J Biol Sci; 2021; 17(10):2622-2632. PubMed ID: 34326698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of BCCIP predicts an unfavorable prognosis and promotes the proliferation and migration of lung adenocarcinoma.
    Shi J; Lv X; Li W; Ming Z; Zeng L; Yuan J; Chen Y; Liu B; Yang S
    Thorac Cancer; 2021 Sep; 12(17):2324-2338. PubMed ID: 34297484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EphrinA3 is a key regulator of malignant behaviors and a potential prognostic factor in lung adenocarcinoma.
    Yiminniyaze R; Zhang X; Zhu N; Wang J; Li C; Wumaier G; Zhou D; Li J; Xia J; Zhang Y; Dong L; Zhang Y; Li S
    Cancer Med; 2023 Jan; 12(2):1630-1642. PubMed ID: 35770949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of microsomal glutathione S-transferase 1 inhibits lung adenocarcinoma cell proliferation and induces apoptosis.
    Zeng B; Ge C; Li R; Zhang Z; Fu Q; Li Z; Lin Z; Liu L; Xue Y; Xu Y; He J; Guo H; Li C; Huang W; Song X; Huang Y
    Biomed Pharmacother; 2020 Jan; 121():109562. PubMed ID: 31707341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing of CD147 inhibits cell proliferation, migration, invasion, lipid metabolism dysregulation and promotes apoptosis in lung adenocarcinoma via blocking the Rap1 signaling pathway.
    Zhang N; Liu Z; Lai X; Liu S; Wang Y
    Respir Res; 2023 Oct; 24(1):253. PubMed ID: 37880644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SOX9 promotes the invasion and migration of lung adenocarcinoma cells by activating the RAP1 signaling pathway.
    Yang JF; Liao Q; Lu CL
    BMC Pulm Med; 2023 Nov; 23(1):421. PubMed ID: 37919693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
    Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y
    Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxic tumor-derived exosomal miR-31-5p promotes lung adenocarcinoma metastasis by negatively regulating SATB2-reversed EMT and activating MEK/ERK signaling.
    Yu F; Liang M; Huang Y; Wu W; Zheng B; Chen C
    J Exp Clin Cancer Res; 2021 Jun; 40(1):179. PubMed ID: 34074322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.